Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Recruiting now · Not applicable

Conditions studied: Lung Carcinoma

In brief

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

Key facts

Study ID

NCT05407168

Run by

OHSU Knight Cancer Institute

People needed

300

Starts

2022-10-31

Expected to finish

2027-12-31

Last updated by the study team

2026-06-25

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• AIM 1: Suspected lung cancer
• AIM 1: English fluency
• AIM 1: > 6-month life expectancy
• AIM 1: Score of ≥ 3 on the cognitive impairment screener
• AIM 2 PARTICIPANTS: Participation in Aim 1
• AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants

Where it is running

• Hillsboro Medical Center — Hillsboro, Oregon, United States (enrolling)
• Adventist Health Portland — Portland, Oregon, United States (enrolling)
• OHSU Knight Cancer Institute — Portland, Oregon, United States (enrolling)
• Portland VA Medical Center — Portland, Oregon, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.